Top conditions
Top treatments
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
This study includes two periods. The main objective of Period 1 is to compare the efficacy of upadacitinib 15 mg once daily (QD) and 30 mg QD versus...
The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the...
Clinical trials
Research sites
Resources
Legal